针对性辅导以改善骨质疏松症治疗的坚持:C-STOP研究的单臂变化
Carrie Ye1, Finlay A McAlister1, Debbie Bellerose1
1Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Journal of bone metabolism
|March 14, 2024
概括
在骨折患者中,案例经理的指导并没有改善骨质疏松症药物坚持. 抑郁症是不坚持的关键因素,突出了未来骨质疏松症干预研究的领域.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 上肢骨折后的骨质疏松症管理对于预防随后的骨折至关重要.
- 针对骨质疏松症预防骨折的比较策略 (C-STOP) 试验先前评估了干预措施.
- 这项研究评估了病例经理 (CM) 辅导是否可以提高药物坚持和持续性.
研究的目的:
- 为了确定由病例经理进行的坚持特定的指导是否可以改善口服双酸盐的坚持和坚持,在骨折后的老年人中.
- 评估CM辅导对坚持和维生素D补充剂的影响.
- 为了确定骨质疏松症药物不坚持的预测因素.
主要方法:
- 对50岁以上的成年人进行前性观察性队列研究,这些成年人有上肢骨折.
- 参与者以前没有服用骨质疏松症药物.
- 主要结局:在12个月后对口服双酸盐的坚持 (>80%的剂量);次要结局包括持久性和补充剂的使用.
主要成果:
- 在84名参与者中,有30人接受了口服双酸盐;73.3%的人在3个月内开始服用.
- 12个月的坚持率为77.3%,持久率为95.5%.
- 抑郁症显著预测了12个月的不坚持 (aOR=9.8).
结论:
- 案例经理的坚持具体指导并没有显著改善药物坚持,超出了最初的C-STOP试验结果.
- 这些发现为优化未来骨质疏松症干预研究中的坚持策略提供了见解.
- 抑郁症是改善骨质疏松症药物坚持治疗的关键因素.
更多相关视频
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
9.2K
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.1K
相关概念视频
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
